nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—hypertension	0.62	1	CbGaD
Fosaprepitant—TACR1—vagus nerve—hypertension	0.0173	0.626	CbGeAlD
Fosaprepitant—Aprepitant—TACR3—hypertension	0.00503	0.713	CrCbGaD
Fosaprepitant—TACR1—brainstem—hypertension	0.0029	0.105	CbGeAlD
Fosaprepitant—TACR1—smooth muscle tissue—hypertension	0.00249	0.09	CbGeAlD
Fosaprepitant—TACR1—adrenal gland—hypertension	0.00187	0.0677	CbGeAlD
Fosaprepitant—TACR1—endocrine gland—hypertension	0.00163	0.0587	CbGeAlD
Fosaprepitant—Aprepitant—TACR1—hypertension	0.00152	0.215	CrCbGaD
Fosaprepitant—TACR1—central nervous system—hypertension	0.00146	0.0529	CbGeAlD
Fosaprepitant—Aprepitant—CYP3A5—hypertension	0.000502	0.0712	CrCbGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRB1—hypertension	5.78e-05	0.000449	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—F2R—hypertension	5.77e-05	0.000447	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—UTS2R—hypertension	5.69e-05	0.000441	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPY1R—hypertension	5.69e-05	0.000441	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TACR2—hypertension	5.69e-05	0.000441	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRA2A—hypertension	5.68e-05	0.000441	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—F2—hypertension	5.68e-05	0.000441	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GHRL—hypertension	5.66e-05	0.000439	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CALCA—hypertension	5.59e-05	0.000434	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDNRB—hypertension	5.58e-05	0.000433	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TAC1—hypertension	5.53e-05	0.000429	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADORA1—hypertension	5.47e-05	0.000425	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—BDKRB2—hypertension	5.46e-05	0.000424	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ANXA1—hypertension	5.42e-05	0.000421	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCR3—hypertension	5.42e-05	0.000421	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRBK1—hypertension	5.4e-05	0.000419	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CNR1—hypertension	5.36e-05	0.000416	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PGF—hypertension	5.29e-05	0.00041	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR2B—hypertension	5.29e-05	0.00041	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PPBP—hypertension	5.29e-05	0.00041	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NEDD4L—hypertension	5.29e-05	0.00041	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SST—hypertension	5.27e-05	0.000409	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDNRA—hypertension	5.27e-05	0.000409	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—hypertension	5.26e-05	0.000408	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—DRD3—hypertension	5.25e-05	0.000407	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADRB1—hypertension	5.25e-05	0.000407	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—DRD2—hypertension	5.23e-05	0.000406	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR7—hypertension	5.23e-05	0.000406	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LEPR—hypertension	5.2e-05	0.000403	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NFATC2—hypertension	5.2e-05	0.000403	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—hypertension	5.19e-05	0.000403	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GCG—hypertension	5.18e-05	0.000402	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—hypertension	5.17e-05	0.000402	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADRA2A—hypertension	5.16e-05	0.0004	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6—hypertension	5.15e-05	0.0004	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GHRL—hypertension	5.14e-05	0.000399	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CALCA—hypertension	5.08e-05	0.000394	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL2—hypertension	5.06e-05	0.000393	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ATP2A3—hypertension	4.97e-05	0.000386	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDE4A—hypertension	4.97e-05	0.000386	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—KNG1—hypertension	4.97e-05	0.000385	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—BDKRB2—hypertension	4.96e-05	0.000385	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AGTR1—hypertension	4.94e-05	0.000383	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADRBK1—hypertension	4.9e-05	0.00038	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CNR1—hypertension	4.87e-05	0.000378	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ARHGDIA—hypertension	4.83e-05	0.000375	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADRA1A—hypertension	4.83e-05	0.000375	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—INHBA—hypertension	4.83e-05	0.000375	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL10—hypertension	4.83e-05	0.000374	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CALM2—hypertension	4.81e-05	0.000374	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ROCK2—hypertension	4.77e-05	0.00037	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR7—hypertension	4.75e-05	0.000368	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—DRD2—hypertension	4.75e-05	0.000368	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GCG—hypertension	4.7e-05	0.000365	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRB2—hypertension	4.68e-05	0.000363	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CYSLTR1—hypertension	4.65e-05	0.000361	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AVPR1A—hypertension	4.65e-05	0.000361	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCE—hypertension	4.62e-05	0.000359	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LHB—hypertension	4.6e-05	0.000357	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—VAV3—hypertension	4.57e-05	0.000354	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RGS2—hypertension	4.55e-05	0.000353	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GAL—hypertension	4.55e-05	0.000353	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—KNG1—hypertension	4.51e-05	0.00035	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CRHR1—hypertension	4.49e-05	0.000349	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VIP—hypertension	4.49e-05	0.000349	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CMA1—hypertension	4.49e-05	0.000349	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GNRH1—hypertension	4.49e-05	0.000349	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—UTS2—hypertension	4.49e-05	0.000349	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TRH—hypertension	4.49e-05	0.000349	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AGTR1—hypertension	4.48e-05	0.000348	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GNB3—hypertension	4.46e-05	0.000346	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AVP—hypertension	4.4e-05	0.000341	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL10—hypertension	4.38e-05	0.00034	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—OXTR—hypertension	4.35e-05	0.000338	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GNAS—hypertension	4.34e-05	0.000337	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TRPC3—hypertension	4.31e-05	0.000334	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LRP2—hypertension	4.31e-05	0.000334	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CASR—hypertension	4.31e-05	0.000334	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CX3CR1—hypertension	4.31e-05	0.000334	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADRB2—hypertension	4.25e-05	0.00033	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HDAC6—hypertension	4.23e-05	0.000328	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB1—hypertension	4.23e-05	0.000328	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CX3CL1—hypertension	4.23e-05	0.000328	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCE—hypertension	4.2e-05	0.000326	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—EDN1—hypertension	4.19e-05	0.000325	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCL5—hypertension	4.15e-05	0.000322	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—VAV3—hypertension	4.15e-05	0.000322	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HSPG2—hypertension	4.15e-05	0.000322	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTH—hypertension	4.11e-05	0.000319	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADM—hypertension	4.11e-05	0.000319	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDE4D—hypertension	4.11e-05	0.000319	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GABBR1—hypertension	4.11e-05	0.000319	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRKG1—hypertension	4.11e-05	0.000319	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GNB3—hypertension	4.05e-05	0.000314	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CYBB—hypertension	4.01e-05	0.000311	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GLP1R—hypertension	4.01e-05	0.000311	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL8—hypertension	4e-05	0.000311	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AVP—hypertension	4e-05	0.00031	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hypertension	3.99e-05	0.000309	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADCY5—hypertension	3.98e-05	0.000309	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCG—hypertension	3.95e-05	0.000306	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GNAS—hypertension	3.94e-05	0.000306	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HRH3—hypertension	3.94e-05	0.000306	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCA—hypertension	3.92e-05	0.000304	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDN1—hypertension	3.8e-05	0.000295	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL5—hypertension	3.77e-05	0.000293	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR5—hypertension	3.74e-05	0.00029	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCD—hypertension	3.74e-05	0.00029	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NCF2—hypertension	3.66e-05	0.000284	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2A—hypertension	3.66e-05	0.000284	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—C3—hypertension	3.66e-05	0.000284	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADCY5—hypertension	3.61e-05	0.00028	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCG—hypertension	3.59e-05	0.000278	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VWF—hypertension	3.57e-05	0.000277	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPY—hypertension	3.57e-05	0.000277	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCA—hypertension	3.56e-05	0.000276	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AGT—hypertension	3.47e-05	0.00027	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL2—hypertension	3.44e-05	0.000267	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—OXT—hypertension	3.44e-05	0.000267	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGTR2—hypertension	3.44e-05	0.000267	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR1B—hypertension	3.44e-05	0.000267	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—F2R—hypertension	3.41e-05	0.000264	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFBR1—hypertension	3.41e-05	0.000264	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCD—hypertension	3.4e-05	0.000264	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR5—hypertension	3.4e-05	0.000264	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2A—hypertension	3.33e-05	0.000258	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—C3—hypertension	3.32e-05	0.000258	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NCF1—hypertension	3.3e-05	0.000256	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EDNRB—hypertension	3.3e-05	0.000256	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TAC1—hypertension	3.27e-05	0.000253	CbGpPWpGaD
Fosaprepitant—Vomiting—Verapamil—hypertension	3.26e-05	0.000151	CcSEcCtD
Fosaprepitant—Urticaria—Irbesartan—hypertension	3.26e-05	0.000151	CcSEcCtD
Fosaprepitant—Shock—Ramipril—hypertension	3.26e-05	0.000151	CcSEcCtD
Fosaprepitant—Hypersensitivity—Enalapril—hypertension	3.26e-05	0.000151	CcSEcCtD
Fosaprepitant—Abdominal pain—Perindopril—hypertension	3.26e-05	0.00015	CcSEcCtD
Fosaprepitant—Body temperature increased—Perindopril—hypertension	3.26e-05	0.00015	CcSEcCtD
Fosaprepitant—Palpitations—Lisinopril—hypertension	3.25e-05	0.00015	CcSEcCtD
Fosaprepitant—Diarrhoea—Olmesartan—hypertension	3.25e-05	0.00015	CcSEcCtD
Fosaprepitant—Headache—Eplerenone—hypertension	3.25e-05	0.00015	CcSEcCtD
Fosaprepitant—Rash—Nifedipine—hypertension	3.25e-05	0.00015	CcSEcCtD
Fosaprepitant—Nervous system disorder—Ramipril—hypertension	3.25e-05	0.00015	CcSEcCtD
Fosaprepitant—Dermatitis—Nifedipine—hypertension	3.25e-05	0.00015	CcSEcCtD
Fosaprepitant—Abdominal pain—Irbesartan—hypertension	3.24e-05	0.00015	CcSEcCtD
Fosaprepitant—Body temperature increased—Irbesartan—hypertension	3.24e-05	0.00015	CcSEcCtD
Fosaprepitant—Oedema—Timolol—hypertension	3.24e-05	0.00015	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Timolol—hypertension	3.24e-05	0.00015	CcSEcCtD
Fosaprepitant—Loss of consciousness—Lisinopril—hypertension	3.23e-05	0.000149	CcSEcCtD
Fosaprepitant—Rash—Verapamil—hypertension	3.23e-05	0.000149	CcSEcCtD
Fosaprepitant—Urticaria—Hydrochlorothiazide—hypertension	3.23e-05	0.000149	CcSEcCtD
Fosaprepitant—Dermatitis—Verapamil—hypertension	3.23e-05	0.000149	CcSEcCtD
Fosaprepitant—Headache—Nifedipine—hypertension	3.23e-05	0.000149	CcSEcCtD
Fosaprepitant—Pruritus—Clonidine—hypertension	3.22e-05	0.000149	CcSEcCtD
Fosaprepitant—Body temperature increased—Hydrochlorothiazide—hypertension	3.22e-05	0.000149	CcSEcCtD
Fosaprepitant—Abdominal pain—Hydrochlorothiazide—hypertension	3.22e-05	0.000149	CcSEcCtD
Fosaprepitant—Skin disorder—Ramipril—hypertension	3.22e-05	0.000149	CcSEcCtD
Fosaprepitant—Infection—Timolol—hypertension	3.22e-05	0.000149	CcSEcCtD
Fosaprepitant—Headache—Verapamil—hypertension	3.21e-05	0.000148	CcSEcCtD
Fosaprepitant—Hypersensitivity—Telmisartan—hypertension	3.21e-05	0.000148	CcSEcCtD
Fosaprepitant—Cough—Lisinopril—hypertension	3.21e-05	0.000148	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCB—hypertension	3.21e-05	0.000249	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—F2—hypertension	3.21e-05	0.000249	CbGpPWpGaD
Fosaprepitant—Nausea—Indapamide—hypertension	3.21e-05	0.000148	CcSEcCtD
Fosaprepitant—Nausea—Diltiazem—hypertension	3.21e-05	0.000148	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ANXA1—hypertension	3.2e-05	0.000248	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCR3—hypertension	3.2e-05	0.000248	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Ramipril—hypertension	3.2e-05	0.000148	CcSEcCtD
Fosaprepitant—Asthenia—Trandolapril—hypertension	3.19e-05	0.000147	CcSEcCtD
Fosaprepitant—Shock—Timolol—hypertension	3.19e-05	0.000147	CcSEcCtD
Fosaprepitant—Feeling abnormal—Losartan—hypertension	3.18e-05	0.000147	CcSEcCtD
Fosaprepitant—Urticaria—Furosemide—hypertension	3.18e-05	0.000147	CcSEcCtD
Fosaprepitant—Nervous system disorder—Timolol—hypertension	3.18e-05	0.000147	CcSEcCtD
Fosaprepitant—Nausea—Carvedilol—hypertension	3.18e-05	0.000147	CcSEcCtD
Fosaprepitant—Asthenia—Enalapril—hypertension	3.17e-05	0.000147	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—IKBKB—hypertension	3.17e-05	0.000246	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Furosemide—hypertension	3.16e-05	0.000146	CcSEcCtD
Fosaprepitant—Body temperature increased—Furosemide—hypertension	3.16e-05	0.000146	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Losartan—hypertension	3.16e-05	0.000146	CcSEcCtD
Fosaprepitant—Dizziness—Valsartan—hypertension	3.16e-05	0.000146	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—AGT—hypertension	3.16e-05	0.000245	CbGpPWpGaD
Fosaprepitant—Urticaria—Betaxolol—hypertension	3.15e-05	0.000145	CcSEcCtD
Fosaprepitant—Skin disorder—Timolol—hypertension	3.15e-05	0.000145	CcSEcCtD
Fosaprepitant—Dizziness—Olmesartan—hypertension	3.14e-05	0.000145	CcSEcCtD
Fosaprepitant—Pruritus—Trandolapril—hypertension	3.14e-05	0.000145	CcSEcCtD
Fosaprepitant—Nausea—Doxazosin—hypertension	3.14e-05	0.000145	CcSEcCtD
Fosaprepitant—Chest pain—Lisinopril—hypertension	3.13e-05	0.000145	CcSEcCtD
Fosaprepitant—Body temperature increased—Betaxolol—hypertension	3.13e-05	0.000145	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Timolol—hypertension	3.13e-05	0.000145	CcSEcCtD
Fosaprepitant—Asthenia—Telmisartan—hypertension	3.13e-05	0.000145	CcSEcCtD
Fosaprepitant—Pruritus—Enalapril—hypertension	3.13e-05	0.000145	CcSEcCtD
Fosaprepitant—Anxiety—Lisinopril—hypertension	3.12e-05	0.000144	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SST—hypertension	3.12e-05	0.000242	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EDNRA—hypertension	3.12e-05	0.000242	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Clonidine—hypertension	3.11e-05	0.000144	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	3.11e-05	0.000144	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CALM1—hypertension	3.1e-05	0.000241	CbGpPWpGaD
Fosaprepitant—Nausea—Fosinopril—hypertension	3.1e-05	0.000143	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CYBA—hypertension	3.1e-05	0.000241	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADRB1—hypertension	3.1e-05	0.000241	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FLT1—hypertension	3.1e-05	0.000241	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DRD3—hypertension	3.1e-05	0.000241	CbGpPWpGaD
Fosaprepitant—Discomfort—Lisinopril—hypertension	3.1e-05	0.000143	CcSEcCtD
Fosaprepitant—Hypotension—Ramipril—hypertension	3.09e-05	0.000143	CcSEcCtD
Fosaprepitant—Pruritus—Telmisartan—hypertension	3.09e-05	0.000143	CcSEcCtD
Fosaprepitant—Nausea—Eplerenone—hypertension	3.08e-05	0.000142	CcSEcCtD
Fosaprepitant—Urticaria—Losartan—hypertension	3.07e-05	0.000142	CcSEcCtD
Fosaprepitant—Dry mouth—Lisinopril—hypertension	3.06e-05	0.000142	CcSEcCtD
Fosaprepitant—Nausea—Nifedipine—hypertension	3.06e-05	0.000141	CcSEcCtD
Fosaprepitant—Abdominal pain—Losartan—hypertension	3.05e-05	0.000141	CcSEcCtD
Fosaprepitant—Body temperature increased—Losartan—hypertension	3.05e-05	0.000141	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADRA2A—hypertension	3.05e-05	0.000237	CbGpPWpGaD
Fosaprepitant—Nausea—Verapamil—hypertension	3.05e-05	0.000141	CcSEcCtD
Fosaprepitant—Asthenia—Captopril—hypertension	3.04e-05	0.000141	CcSEcCtD
Fosaprepitant—Diarrhoea—Trandolapril—hypertension	3.04e-05	0.00014	CcSEcCtD
Fosaprepitant—Vomiting—Valsartan—hypertension	3.04e-05	0.00014	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PLAT—hypertension	3.04e-05	0.000236	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GHRL—hypertension	3.04e-05	0.000236	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Enalapril—hypertension	3.03e-05	0.00014	CcSEcCtD
Fosaprepitant—Hypotension—Timolol—hypertension	3.03e-05	0.00014	CcSEcCtD
Fosaprepitant—Hypersensitivity—Irbesartan—hypertension	3.02e-05	0.00014	CcSEcCtD
Fosaprepitant—Vomiting—Olmesartan—hypertension	3.02e-05	0.00014	CcSEcCtD
Fosaprepitant—Rash—Valsartan—hypertension	3.01e-05	0.000139	CcSEcCtD
Fosaprepitant—Dizziness—Clonidine—hypertension	3.01e-05	0.000139	CcSEcCtD
Fosaprepitant—Dermatitis—Valsartan—hypertension	3.01e-05	0.000139	CcSEcCtD
Fosaprepitant—Oedema—Lisinopril—hypertension	3e-05	0.000139	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Lisinopril—hypertension	3e-05	0.000139	CcSEcCtD
Fosaprepitant—Pruritus—Captopril—hypertension	3e-05	0.000139	CcSEcCtD
Fosaprepitant—Hypersensitivity—Hydrochlorothiazide—hypertension	3e-05	0.000139	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CALCA—hypertension	3e-05	0.000233	CbGpPWpGaD
Fosaprepitant—Rash—Olmesartan—hypertension	3e-05	0.000138	CcSEcCtD
Fosaprepitant—Insomnia—Ramipril—hypertension	3e-05	0.000138	CcSEcCtD
Fosaprepitant—Dermatitis—Olmesartan—hypertension	2.99e-05	0.000138	CcSEcCtD
Fosaprepitant—Headache—Valsartan—hypertension	2.99e-05	0.000138	CcSEcCtD
Fosaprepitant—Diarrhoea—Telmisartan—hypertension	2.98e-05	0.000138	CcSEcCtD
Fosaprepitant—Infection—Lisinopril—hypertension	2.98e-05	0.000138	CcSEcCtD
Fosaprepitant—Headache—Olmesartan—hypertension	2.98e-05	0.000138	CcSEcCtD
Fosaprepitant—Shock—Lisinopril—hypertension	2.96e-05	0.000137	CcSEcCtD
Fosaprepitant—Asthenia—Perindopril—hypertension	2.95e-05	0.000136	CcSEcCtD
Fosaprepitant—Dyspnoea—Ramipril—hypertension	2.95e-05	0.000136	CcSEcCtD
Fosaprepitant—Hypersensitivity—Furosemide—hypertension	2.95e-05	0.000136	CcSEcCtD
Fosaprepitant—Asthenia—Irbesartan—hypertension	2.94e-05	0.000136	CcSEcCtD
Fosaprepitant—Somnolence—Ramipril—hypertension	2.94e-05	0.000136	CcSEcCtD
Fosaprepitant—Dizziness—Trandolapril—hypertension	2.94e-05	0.000136	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB2—hypertension	2.93e-05	0.000227	CbGpPWpGaD
Fosaprepitant—Insomnia—Timolol—hypertension	2.93e-05	0.000135	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—hypertension	2.92e-05	0.000227	CbGpPWpGaD
Fosaprepitant—Dizziness—Enalapril—hypertension	2.92e-05	0.000135	CcSEcCtD
Fosaprepitant—Asthenia—Hydrochlorothiazide—hypertension	2.92e-05	0.000135	CcSEcCtD
Fosaprepitant—Hypersensitivity—Betaxolol—hypertension	2.92e-05	0.000135	CcSEcCtD
Fosaprepitant—Skin disorder—Lisinopril—hypertension	2.92e-05	0.000135	CcSEcCtD
Fosaprepitant—Dyspepsia—Ramipril—hypertension	2.92e-05	0.000135	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—F2—hypertension	2.92e-05	0.000226	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCB—hypertension	2.92e-05	0.000226	CbGpPWpGaD
Fosaprepitant—Pruritus—Perindopril—hypertension	2.91e-05	0.000135	CcSEcCtD
Fosaprepitant—Pruritus—Irbesartan—hypertension	2.9e-05	0.000134	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Lisinopril—hypertension	2.9e-05	0.000134	CcSEcCtD
Fosaprepitant—Diarrhoea—Captopril—hypertension	2.9e-05	0.000134	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADRBK1—hypertension	2.9e-05	0.000225	CbGpPWpGaD
Fosaprepitant—Vomiting—Clonidine—hypertension	2.89e-05	0.000134	CcSEcCtD
Fosaprepitant—Dyspnoea—Timolol—hypertension	2.89e-05	0.000133	CcSEcCtD
Fosaprepitant—Dizziness—Telmisartan—hypertension	2.88e-05	0.000133	CcSEcCtD
Fosaprepitant—Pruritus—Hydrochlorothiazide—hypertension	2.88e-05	0.000133	CcSEcCtD
Fosaprepitant—Decreased appetite—Ramipril—hypertension	2.88e-05	0.000133	CcSEcCtD
Fosaprepitant—Somnolence—Timolol—hypertension	2.88e-05	0.000133	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CNR1—hypertension	2.87e-05	0.000223	CbGpPWpGaD
Fosaprepitant—Asthenia—Furosemide—hypertension	2.87e-05	0.000133	CcSEcCtD
Fosaprepitant—Rash—Clonidine—hypertension	2.87e-05	0.000133	CcSEcCtD
Fosaprepitant—Dermatitis—Clonidine—hypertension	2.87e-05	0.000132	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Ramipril—hypertension	2.86e-05	0.000132	CcSEcCtD
Fosaprepitant—Fatigue—Ramipril—hypertension	2.86e-05	0.000132	CcSEcCtD
Fosaprepitant—Headache—Clonidine—hypertension	2.85e-05	0.000132	CcSEcCtD
Fosaprepitant—Dyspepsia—Timolol—hypertension	2.85e-05	0.000132	CcSEcCtD
Fosaprepitant—Hypersensitivity—Losartan—hypertension	2.85e-05	0.000131	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CALM2—hypertension	2.84e-05	0.000221	CbGpPWpGaD
Fosaprepitant—Asthenia—Betaxolol—hypertension	2.84e-05	0.000131	CcSEcCtD
Fosaprepitant—Nausea—Valsartan—hypertension	2.84e-05	0.000131	CcSEcCtD
Fosaprepitant—Pruritus—Furosemide—hypertension	2.83e-05	0.000131	CcSEcCtD
Fosaprepitant—Constipation—Ramipril—hypertension	2.83e-05	0.000131	CcSEcCtD
Fosaprepitant—Nausea—Olmesartan—hypertension	2.82e-05	0.00013	CcSEcCtD
Fosaprepitant—Vomiting—Trandolapril—hypertension	2.82e-05	0.00013	CcSEcCtD
Fosaprepitant—Diarrhoea—Perindopril—hypertension	2.82e-05	0.00013	CcSEcCtD
Fosaprepitant—Decreased appetite—Timolol—hypertension	2.81e-05	0.00013	CcSEcCtD
Fosaprepitant—Vomiting—Enalapril—hypertension	2.81e-05	0.00013	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—AKT2—hypertension	2.81e-05	0.000218	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Irbesartan—hypertension	2.81e-05	0.00013	CcSEcCtD
Fosaprepitant—Hypotension—Lisinopril—hypertension	2.81e-05	0.00013	CcSEcCtD
Fosaprepitant—Dizziness—Captopril—hypertension	2.8e-05	0.00013	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—DRD2—hypertension	2.8e-05	0.000218	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR7—hypertension	2.8e-05	0.000218	CbGpPWpGaD
Fosaprepitant—Pruritus—Betaxolol—hypertension	2.8e-05	0.00013	CcSEcCtD
Fosaprepitant—Rash—Trandolapril—hypertension	2.8e-05	0.000129	CcSEcCtD
Fosaprepitant—Dermatitis—Trandolapril—hypertension	2.8e-05	0.000129	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Timolol—hypertension	2.8e-05	0.000129	CcSEcCtD
Fosaprepitant—Fatigue—Timolol—hypertension	2.79e-05	0.000129	CcSEcCtD
Fosaprepitant—Rash—Enalapril—hypertension	2.79e-05	0.000129	CcSEcCtD
Fosaprepitant—Dermatitis—Enalapril—hypertension	2.79e-05	0.000129	CcSEcCtD
Fosaprepitant—Diarrhoea—Hydrochlorothiazide—hypertension	2.79e-05	0.000129	CcSEcCtD
Fosaprepitant—Headache—Trandolapril—hypertension	2.78e-05	0.000129	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—GCG—hypertension	2.78e-05	0.000215	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTPN1—hypertension	2.78e-05	0.000215	CbGpPWpGaD
Fosaprepitant—Vomiting—Telmisartan—hypertension	2.77e-05	0.000128	CcSEcCtD
Fosaprepitant—Asthenia—Losartan—hypertension	2.77e-05	0.000128	CcSEcCtD
Fosaprepitant—Headache—Enalapril—hypertension	2.77e-05	0.000128	CcSEcCtD
Fosaprepitant—Pain—Timolol—hypertension	2.77e-05	0.000128	CcSEcCtD
Fosaprepitant—Rash—Telmisartan—hypertension	2.75e-05	0.000127	CcSEcCtD
Fosaprepitant—Dermatitis—Telmisartan—hypertension	2.75e-05	0.000127	CcSEcCtD
Fosaprepitant—Diarrhoea—Furosemide—hypertension	2.74e-05	0.000127	CcSEcCtD
Fosaprepitant—Pruritus—Losartan—hypertension	2.73e-05	0.000126	CcSEcCtD
Fosaprepitant—Headache—Telmisartan—hypertension	2.73e-05	0.000126	CcSEcCtD
Fosaprepitant—Feeling abnormal—Ramipril—hypertension	2.73e-05	0.000126	CcSEcCtD
Fosaprepitant—Dizziness—Perindopril—hypertension	2.72e-05	0.000126	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NOTCH2—hypertension	2.72e-05	0.000211	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KL—hypertension	2.72e-05	0.000211	CbGpPWpGaD
Fosaprepitant—Insomnia—Lisinopril—hypertension	2.72e-05	0.000126	CcSEcCtD
Fosaprepitant—Dizziness—Irbesartan—hypertension	2.71e-05	0.000125	CcSEcCtD
Fosaprepitant—Diarrhoea—Betaxolol—hypertension	2.71e-05	0.000125	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Ramipril—hypertension	2.71e-05	0.000125	CcSEcCtD
Fosaprepitant—Nausea—Clonidine—hypertension	2.7e-05	0.000125	CcSEcCtD
Fosaprepitant—Vomiting—Captopril—hypertension	2.7e-05	0.000125	CcSEcCtD
Fosaprepitant—Dizziness—Hydrochlorothiazide—hypertension	2.69e-05	0.000124	CcSEcCtD
Fosaprepitant—Dyspnoea—Lisinopril—hypertension	2.68e-05	0.000124	CcSEcCtD
Fosaprepitant—Rash—Captopril—hypertension	2.67e-05	0.000124	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ITGAV—hypertension	2.67e-05	0.000207	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NGFR—hypertension	2.67e-05	0.000207	CbGpPWpGaD
Fosaprepitant—Dermatitis—Captopril—hypertension	2.67e-05	0.000123	CcSEcCtD
Fosaprepitant—Somnolence—Lisinopril—hypertension	2.67e-05	0.000123	CcSEcCtD
Fosaprepitant—Feeling abnormal—Timolol—hypertension	2.67e-05	0.000123	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—KNG1—hypertension	2.66e-05	0.000207	CbGpPWpGaD
Fosaprepitant—Headache—Captopril—hypertension	2.66e-05	0.000123	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—hypertension	2.66e-05	0.000206	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRL—hypertension	2.65e-05	0.000206	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGTR1—hypertension	2.65e-05	0.000206	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Timolol—hypertension	2.65e-05	0.000122	CcSEcCtD
Fosaprepitant—Dizziness—Furosemide—hypertension	2.65e-05	0.000122	CcSEcCtD
Fosaprepitant—Dyspepsia—Lisinopril—hypertension	2.64e-05	0.000122	CcSEcCtD
Fosaprepitant—Diarrhoea—Losartan—hypertension	2.64e-05	0.000122	CcSEcCtD
Fosaprepitant—Nausea—Trandolapril—hypertension	2.64e-05	0.000122	CcSEcCtD
Fosaprepitant—Urticaria—Ramipril—hypertension	2.63e-05	0.000122	CcSEcCtD
Fosaprepitant—Nausea—Enalapril—hypertension	2.63e-05	0.000121	CcSEcCtD
Fosaprepitant—Dizziness—Betaxolol—hypertension	2.62e-05	0.000121	CcSEcCtD
Fosaprepitant—Vomiting—Perindopril—hypertension	2.62e-05	0.000121	CcSEcCtD
Fosaprepitant—Abdominal pain—Ramipril—hypertension	2.62e-05	0.000121	CcSEcCtD
Fosaprepitant—Body temperature increased—Ramipril—hypertension	2.62e-05	0.000121	CcSEcCtD
Fosaprepitant—Decreased appetite—Lisinopril—hypertension	2.61e-05	0.000121	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—STK11—hypertension	2.61e-05	0.000203	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HDAC1—hypertension	2.61e-05	0.000203	CbGpPWpGaD
Fosaprepitant—Vomiting—Irbesartan—hypertension	2.61e-05	0.000121	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCL2—hypertension	2.6e-05	0.000202	CbGpPWpGaD
Fosaprepitant—Rash—Perindopril—hypertension	2.6e-05	0.00012	CcSEcCtD
Fosaprepitant—Dermatitis—Perindopril—hypertension	2.59e-05	0.00012	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Lisinopril—hypertension	2.59e-05	0.00012	CcSEcCtD
Fosaprepitant—Nausea—Telmisartan—hypertension	2.59e-05	0.00012	CcSEcCtD
Fosaprepitant—Fatigue—Lisinopril—hypertension	2.59e-05	0.00012	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CXCL10—hypertension	2.59e-05	0.000201	CbGpPWpGaD
Fosaprepitant—Vomiting—Hydrochlorothiazide—hypertension	2.59e-05	0.00012	CcSEcCtD
Fosaprepitant—Rash—Irbesartan—hypertension	2.59e-05	0.00012	CcSEcCtD
Fosaprepitant—Dermatitis—Irbesartan—hypertension	2.59e-05	0.000119	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PLG—hypertension	2.58e-05	0.0002	CbGpPWpGaD
Fosaprepitant—Headache—Perindopril—hypertension	2.58e-05	0.000119	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—RHOA—hypertension	2.58e-05	0.0002	CbGpPWpGaD
Fosaprepitant—Urticaria—Timolol—hypertension	2.57e-05	0.000119	CcSEcCtD
Fosaprepitant—Headache—Irbesartan—hypertension	2.57e-05	0.000119	CcSEcCtD
Fosaprepitant—Constipation—Lisinopril—hypertension	2.57e-05	0.000119	CcSEcCtD
Fosaprepitant—Pain—Lisinopril—hypertension	2.57e-05	0.000119	CcSEcCtD
Fosaprepitant—Rash—Hydrochlorothiazide—hypertension	2.57e-05	0.000119	CcSEcCtD
Fosaprepitant—Dermatitis—Hydrochlorothiazide—hypertension	2.56e-05	0.000118	CcSEcCtD
Fosaprepitant—Body temperature increased—Timolol—hypertension	2.56e-05	0.000118	CcSEcCtD
Fosaprepitant—Abdominal pain—Timolol—hypertension	2.56e-05	0.000118	CcSEcCtD
Fosaprepitant—Dizziness—Losartan—hypertension	2.55e-05	0.000118	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—AKT2—hypertension	2.55e-05	0.000198	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PIK3R1—hypertension	2.55e-05	0.000198	CbGpPWpGaD
Fosaprepitant—Headache—Hydrochlorothiazide—hypertension	2.55e-05	0.000118	CcSEcCtD
Fosaprepitant—Vomiting—Furosemide—hypertension	2.55e-05	0.000118	CcSEcCtD
Fosaprepitant—Rash—Furosemide—hypertension	2.52e-05	0.000117	CcSEcCtD
Fosaprepitant—Dermatitis—Furosemide—hypertension	2.52e-05	0.000117	CcSEcCtD
Fosaprepitant—Vomiting—Betaxolol—hypertension	2.52e-05	0.000116	CcSEcCtD
Fosaprepitant—Nausea—Captopril—hypertension	2.52e-05	0.000116	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADRB2—hypertension	2.51e-05	0.000195	CbGpPWpGaD
Fosaprepitant—Headache—Furosemide—hypertension	2.51e-05	0.000116	CcSEcCtD
Fosaprepitant—Rash—Betaxolol—hypertension	2.5e-05	0.000115	CcSEcCtD
Fosaprepitant—Dermatitis—Betaxolol—hypertension	2.5e-05	0.000115	CcSEcCtD
Fosaprepitant—Headache—Betaxolol—hypertension	2.48e-05	0.000115	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PRKCE—hypertension	2.48e-05	0.000193	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Lisinopril—hypertension	2.48e-05	0.000114	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Lisinopril—hypertension	2.46e-05	0.000113	CcSEcCtD
Fosaprepitant—Vomiting—Losartan—hypertension	2.46e-05	0.000113	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—VAV3—hypertension	2.45e-05	0.00019	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDGFA—hypertension	2.45e-05	0.00019	CbGpPWpGaD
Fosaprepitant—Nausea—Perindopril—hypertension	2.45e-05	0.000113	CcSEcCtD
Fosaprepitant—Hypersensitivity—Ramipril—hypertension	2.44e-05	0.000113	CcSEcCtD
Fosaprepitant—Nausea—Irbesartan—hypertension	2.44e-05	0.000113	CcSEcCtD
Fosaprepitant—Rash—Losartan—hypertension	2.44e-05	0.000113	CcSEcCtD
Fosaprepitant—Dermatitis—Losartan—hypertension	2.43e-05	0.000112	CcSEcCtD
Fosaprepitant—Headache—Losartan—hypertension	2.42e-05	0.000112	CcSEcCtD
Fosaprepitant—Nausea—Hydrochlorothiazide—hypertension	2.42e-05	0.000112	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—TGFBR2—hypertension	2.42e-05	0.000187	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GNB3—hypertension	2.39e-05	0.000186	CbGpPWpGaD
Fosaprepitant—Urticaria—Lisinopril—hypertension	2.39e-05	0.00011	CcSEcCtD
Fosaprepitant—Hypersensitivity—Timolol—hypertension	2.39e-05	0.00011	CcSEcCtD
Fosaprepitant—Nausea—Furosemide—hypertension	2.38e-05	0.00011	CcSEcCtD
Fosaprepitant—Asthenia—Ramipril—hypertension	2.38e-05	0.00011	CcSEcCtD
Fosaprepitant—Body temperature increased—Lisinopril—hypertension	2.37e-05	0.00011	CcSEcCtD
Fosaprepitant—Abdominal pain—Lisinopril—hypertension	2.37e-05	0.00011	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—AVP—hypertension	2.36e-05	0.000183	CbGpPWpGaD
Fosaprepitant—Nausea—Betaxolol—hypertension	2.35e-05	0.000109	CcSEcCtD
Fosaprepitant—Pruritus—Ramipril—hypertension	2.34e-05	0.000108	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—RHOA—hypertension	2.34e-05	0.000182	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GNAS—hypertension	2.33e-05	0.000181	CbGpPWpGaD
Fosaprepitant—Asthenia—Timolol—hypertension	2.32e-05	0.000107	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—PIK3R1—hypertension	2.32e-05	0.00018	CbGpPWpGaD
Fosaprepitant—Nausea—Losartan—hypertension	2.29e-05	0.000106	CcSEcCtD
Fosaprepitant—Pruritus—Timolol—hypertension	2.29e-05	0.000106	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—APOB—hypertension	2.28e-05	0.000177	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTK2—hypertension	2.27e-05	0.000176	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Ramipril—hypertension	2.27e-05	0.000105	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL8—hypertension	2.26e-05	0.000176	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EDN1—hypertension	2.25e-05	0.000174	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL5—hypertension	2.23e-05	0.000173	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Timolol—hypertension	2.22e-05	0.000102	CcSEcCtD
Fosaprepitant—Hypersensitivity—Lisinopril—hypertension	2.21e-05	0.000102	CcSEcCtD
Fosaprepitant—Dizziness—Ramipril—hypertension	2.19e-05	0.000101	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—LPL—hypertension	2.18e-05	0.000169	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—H2AFX—hypertension	2.16e-05	0.000168	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RPS6KB1—hypertension	2.16e-05	0.000168	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDGFRB—hypertension	2.16e-05	0.000168	CbGpPWpGaD
Fosaprepitant—Asthenia—Lisinopril—hypertension	2.16e-05	9.96e-05	CcSEcCtD
Fosaprepitant—Dizziness—Timolol—hypertension	2.14e-05	9.89e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADCY5—hypertension	2.13e-05	0.000165	CbGpPWpGaD
Fosaprepitant—Pruritus—Lisinopril—hypertension	2.13e-05	9.82e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PRKCG—hypertension	2.12e-05	0.000164	CbGpPWpGaD
Fosaprepitant—Vomiting—Ramipril—hypertension	2.11e-05	9.73e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ITGB3—hypertension	2.1e-05	0.000163	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRKCA—hypertension	2.1e-05	0.000163	CbGpPWpGaD
Fosaprepitant—Rash—Ramipril—hypertension	2.09e-05	9.65e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—YWHAZ—hypertension	2.09e-05	0.000162	CbGpPWpGaD
Fosaprepitant—Dermatitis—Ramipril—hypertension	2.09e-05	9.64e-05	CcSEcCtD
Fosaprepitant—Headache—Ramipril—hypertension	2.07e-05	9.59e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SPP1—hypertension	2.06e-05	0.00016	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NGF—hypertension	2.06e-05	0.00016	CbGpPWpGaD
Fosaprepitant—Vomiting—Timolol—hypertension	2.06e-05	9.51e-05	CcSEcCtD
Fosaprepitant—Diarrhoea—Lisinopril—hypertension	2.06e-05	9.49e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL8—hypertension	2.05e-05	0.000159	CbGpPWpGaD
Fosaprepitant—Rash—Timolol—hypertension	2.04e-05	9.43e-05	CcSEcCtD
Fosaprepitant—Dermatitis—Timolol—hypertension	2.04e-05	9.42e-05	CcSEcCtD
Fosaprepitant—Headache—Timolol—hypertension	2.03e-05	9.37e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR5—hypertension	2.01e-05	0.000156	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRKCD—hypertension	2.01e-05	0.000156	CbGpPWpGaD
Fosaprepitant—Dizziness—Lisinopril—hypertension	1.99e-05	9.18e-05	CcSEcCtD
Fosaprepitant—Nausea—Ramipril—hypertension	1.97e-05	9.09e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HTR2A—hypertension	1.96e-05	0.000152	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—C3—hypertension	1.96e-05	0.000152	CbGpPWpGaD
Fosaprepitant—Nausea—Timolol—hypertension	1.92e-05	8.89e-05	CcSEcCtD
Fosaprepitant—Vomiting—Lisinopril—hypertension	1.91e-05	8.82e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PDGFB—hypertension	1.91e-05	0.000148	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGFR1—hypertension	1.9e-05	0.000147	CbGpPWpGaD
Fosaprepitant—Rash—Lisinopril—hypertension	1.89e-05	8.75e-05	CcSEcCtD
Fosaprepitant—Dermatitis—Lisinopril—hypertension	1.89e-05	8.74e-05	CcSEcCtD
Fosaprepitant—Headache—Lisinopril—hypertension	1.88e-05	8.69e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HIF1A—hypertension	1.87e-05	0.000145	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGT—hypertension	1.86e-05	0.000145	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CALM1—hypertension	1.83e-05	0.000142	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LEP—hypertension	1.83e-05	0.000142	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOE—hypertension	1.83e-05	0.000142	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CAV1—hypertension	1.81e-05	0.00014	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOA1—hypertension	1.81e-05	0.00014	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KDR—hypertension	1.79e-05	0.000139	CbGpPWpGaD
Fosaprepitant—Nausea—Lisinopril—hypertension	1.78e-05	8.24e-05	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—FN1—hypertension	1.72e-05	0.000134	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—F2—hypertension	1.72e-05	0.000134	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRKCB—hypertension	1.72e-05	0.000134	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOTCH1—hypertension	1.69e-05	0.000131	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—POMC—hypertension	1.57e-05	0.000122	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—INS—hypertension	1.56e-05	0.000121	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL2—hypertension	1.54e-05	0.000119	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IGF1—hypertension	1.51e-05	0.000117	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AKT2—hypertension	1.51e-05	0.000117	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EGFR—hypertension	1.5e-05	0.000117	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SERPINE1—hypertension	1.43e-05	0.000111	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGF2—hypertension	1.39e-05	0.000108	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RHOA—hypertension	1.38e-05	0.000107	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PIK3R1—hypertension	1.37e-05	0.000106	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOS3—hypertension	1.37e-05	0.000106	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RELA—hypertension	1.29e-05	9.99e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MTOR—hypertension	1.26e-05	9.8e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL8—hypertension	1.21e-05	9.42e-05	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AKT1—hypertension	1.17e-05	9.1e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6—hypertension	1.15e-05	8.95e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—hypertension	1.1e-05	8.52e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CDKN1A—hypertension	1.09e-05	8.49e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTEN—hypertension	1.09e-05	8.47e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MAPK8—hypertension	1.07e-05	8.28e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AKT1—hypertension	1.06e-05	8.26e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EP300—hypertension	1.04e-05	8.08e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SRC—hypertension	1.01e-05	7.85e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VEGFA—hypertension	9.86e-06	7.65e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MYC—hypertension	9.07e-06	7.04e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFB1—hypertension	9.05e-06	7.02e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EGFR—hypertension	8.87e-06	6.88e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TP53—hypertension	7.45e-06	5.78e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6—hypertension	6.82e-06	5.29e-05	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AKT1—hypertension	6.29e-06	4.88e-05	CbGpPWpGaD
